Dr. Qunfeng Luo | Organic Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Qunfeng Luo | Organic Chemistry | Best Researcher Award

Dr. Qunfeng Luo , Organic Chemistry ,  Nanchang University, China

Dr. Qunfeng Luo is a dedicated Lecturer at the School of Basic Medical Sciences, Nanchang University, China. With a robust background in organic synthesis and protein chemistry, his research explores innovative approaches in peptide/protein modification and bioorthogonal chemistry. Dr. Luo has made notable contributions to the development of multifunctional bioconjugation reagents and mitochondrion-targeting molecules, with publications featured in top-tier journals like Nature Communications and Organic Letters. He earned his Ph.D. from Nanjing University and has held research positions at prestigious institutions, including Northwestern Polytechnical University. Dr. Luo also brings industry experience from Pharmaron (Ningbo) New Pharmaceutical Technology Co., Ltd. His work bridges chemical biology and therapeutic discovery, particularly focusing on functional biomolecule engineering and natural active ingredient target identification. A proactive researcher with an ORCID profile, he continues to advance translational biomedical science through interdisciplinary innovations.

Professional Profile : 

Orcid

Scopus

Summary of Suitability for Award:

Dr. Luo has demonstrated a solid and progressive academic background, holding a Ph.D. from Nanjing University and postdoctoral experience in both academia and industry. His education from top Chinese institutions equips him with a multidisciplinary foundation in biomedical and pharmaceutical sciences.His research has been published in top-tier journals such as Nature Communications, Organic Letters, and RSC Advances. Notably, his 2019 Nature Communications paper was highlighted in Synfacts, indicating significant recognition in the global scientific community. Dr. Luo’s work spans organic synthesis, peptide/protein modification, mitochondrion-targeting agents, and bioorthogonal chemistry. Dr. Luo has maintained a consistent output of quality research with a clear upward trajectory in the complexity and impact of his work. His continued research activity, mentorship, and involvement in academia strengthen his candidacy. Dr. Qunfeng Luo is a highly suitable candidate for the “Best Researcher Award”. His impactful publications, innovative methodologies in chemical biology, and contributions to targeted therapeutics and diagnostics reflect the qualities sought in a top-tier researcher. His unique blend of academic excellence, industrial insight, and interdisciplinary work makes him not only a prolific scientist but also a future leader in biomedical research. Recognizing Dr. Luo with this award would be both timely and well-deserved.

🎓Education:

Dr. Qunfeng Luo’s academic journey reflects a strong foundation in medical and pharmaceutical sciences. He began his higher education at Harbin Medical University (2005.9–2010.6), where he gained essential knowledge in medical sciences. Building upon this, he pursued a master’s degree at China Pharmaceutical University (2011.9–2014.6), developing a solid base in drug design and bioactive compound synthesis. Driven by a keen interest in chemical biology and therapeutic research, he advanced to Nanjing University (2014.9–2018.12) for his doctoral studies. There, he specialized in organic synthesis and protein/peptide bioconjugation techniques, which laid the groundwork for his current research in bio orthogonal chemistry and target identification. This comprehensive academic training, combining medical, pharmaceutical, and chemical expertise, enables Dr. Luo to contribute significantly to multidisciplinary biomedical research.

🏢Work Experience:

Dr. Qunfeng Luo has held diverse academic and industry positions, enriching his expertise in biomedical sciences. He began his professional journey at Pharmaron (Ningbo) New Pharmaceutical Technology Co., Ltd. (2019.3–2019.9), gaining valuable experience in pharmaceutical R&D. He then transitioned to academia as a research fellow at Northwestern Polytechnical University (2019.9–2020.10), focusing on bioorganic chemistry and molecular modification. Since October 2020, he has served as a Lecturer at the School of Basic Medical Sciences, Nanchang University, where he leads research in peptide modification, mitochondrion-targeting molecules, and functional bioconjugation reagents. Dr. Luo’s balanced experience across academia and industry fosters a translational approach to his research, bridging synthetic chemistry and medical application. His current academic role involves not only high-impact research but also mentoring students and contributing to the university’s biomedical education initiatives.

🏅Awards: 

While specific honors were not detailed, Dr. Qunfeng Luo’s research achievements speak volumes of his recognition in the scientific community. His 2019 Nature Communications publication was highlighted in Synfacts, indicating significant impact in the field of synthetic and chemical biology. Publishing in top-tier journals like Organic Letters and RSC Advances also reflects the high regard in which his work is held. As a young scholar with an innovative portfolio in bioorthogonal chemistry, peptide/protein modification, and mitochondrion-targeting agents, Dr. Luo is well-positioned for future awards and funding opportunities. His diverse background, including experience in pharmaceutical R&D and academia, contributes to his growing influence in biomedical research. As he continues to contribute to high-impact projects and interdisciplinary science, further accolades are expected.

🔬Research Focus:

Dr. Qunfeng Luo’s research lies at the intersection of organic chemistry and biomedical sciences. His primary interests include organic synthesis, peptide and protein modification, and bioorthogonal chemistry—innovative fields that enable precise molecular labeling and therapeutic design. A major focus of his work is developing heterobifunctional cross-linkers that facilitate selective bioconjugation, peptide stapling, and mitochondrial targeting. He also explores target identification of natural active ingredients, contributing to drug discovery and understanding bioactivity mechanisms. His recent publications reveal an emphasis on multifunctional bioconjugation reagents with broad applications in diagnostics and targeted therapies. The integration of small molecule design with functional biomolecules positions his research within both fundamental and translational biomedical innovation. Through interdisciplinary collaborations and advanced chemical techniques, Dr. Luo’s work contributes to the development of precision tools for chemical biology and therapeutic interventions.

Publication Top Notes:

1. Heterobifunctional Cross-Linker with Dinitroimidazole and Azide Modules for Protein and Oligonucleotide Functionalization

2. Heterobifunctional Cross-Linker with Dinitroimidazole and N-Hydroxysuccinimide Ester Motifs for Protein Functionalization and Cysteine–Lysine Peptide Stapling

3. Combination Therapies against COVID-19

4. Dichloroacetophenone Derivatives: A Class of Bioconjugation Reagents for Disulfide Bridging

5. Dinitroimidazoles as Bifunctional Bioconjugation Reagents for Protein Functionalization and Peptide Macrocyclization

6. Recent Advances in Enone and NO-Releasing Derivatives of Oleanolic Acid with Anti-cancer Activity

 

 

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Ph.D., Master’s Supervisor at Inner Mongolia Medical University, School of Basic Medical Sciences, China 

Dr. Pengwei Zhao is a Professor at the School of Basic Medical Sciences, Inner Mongolia Medical University, he serves as a master’s supervisor and holds various academic positions. He is a member of the Jiusan Society and actively contributes to scientific research as a registered reviewer for Medical Science Monitor and Chinese Journal of Tissue Engineering Research. He is also a youth editorial board member of Modern Oncology and a director of the Inner Mongolia Bioengineering Society. His research focuses on tumor immunology and pharmacological mechanisms of Mongolian medicine. Dr. Zhao has led multiple national and regional research projects, including studies on β-defensins, immune resistance, and cancer treatment mechanisms. His contributions to microbiology and oncology are widely recognized, with several impactful publications in international journals.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Pengwei Zhao, a distinguished Professor at Inner Mongolia Medical University, has made significant contributions to tumor immunology, cancer pharmacology, and Mongolian medicine. His research on β-defensins and their role in immune modulation and cancer therapy has led to groundbreaking findings, particularly in colorectal and triple-negative breast cancer (TNBC). With numerous high-impact publications, including in Pharmacogenomics Journal and World Journal of Gastrointestinal Oncology, his work is recognized globally. His ongoing National Natural Science Foundation of China project further highlights his leadership in cancer research.  Dr. Pengwei Zhao’s extensive research, innovative methodologies, and interdisciplinary approach make him an outstanding candidate for the “Best Researcher Award”. His contributions to immunotherapy, autophagy, and microbiome-related cancer treatments have the potential to shape future oncological therapies. Recognizing him with this award would honor his pioneering discoveries and impact on global cancer research.

🎓Education:

Dr. Pengwei Zhao holds a Ph.D. in Basic Medical Sciences with a specialization in tumor immunology and pharmacology. His doctoral research focused on β-defensin-mediated immune modulation and cancer therapy. He pursued his higher education at Inner Mongolia Medical University, where he developed expertise in molecular biology, pharmacology, and immunology. His early education emphasized microbiology and traditional Mongolian medicine. Dr. Zhao further enhanced his skills through postdoctoral research and collaborations with leading scientists in cancer biology. His education provided a strong foundation in oncological pharmacology, signaling pathways, and immune resistance mechanisms. He has continuously expanded his knowledge through national and international conferences, workshops, and training programs. His academic journey reflects a commitment to translational research, bridging basic science with clinical applications in cancer therapy.

🏢Work Experience:

Dr. Zhao has been a Professor at Inner Mongolia Medical University for several years, where he also serves as a Master’s Supervisor. His professional roles extend beyond teaching, as he holds multiple directorial positions in national and regional scientific societies. He is a reviewer for prestigious journals, including Medical Science Monitor and Chinese Journal of Digestive Diseases. As a youth editorial board member of Modern Oncology, he actively contributes to cancer research. He has successfully led multiple research projects funded by national and regional agencies, focusing on cancer immunology, microbiology, and Mongolian medicine-based therapies. Additionally, Dr. Zhao has conducted collaborative research on β-defensins, autophagy, and immune resistance mechanisms. His expertise in pharmacological pathways and microbial interactions has significantly advanced the understanding of cancer treatment. He has also been invited as a speaker and panelist at various oncology and pharmacology conferences.

🏅Awards: 

Dr. Pengwei Zhao has received multiple prestigious awards and honors in recognition of his contributions to tumor immunology and Mongolian medicine research. He has been honored by the Inner Mongolia Medical University for excellence in research and mentorship. His work on β-defensins and their role in cancer has earned him accolades from Inner Mongolia’s Science and Technology Department. He has also received distinguished reviewer awards from journals such as Medical Science Monitor and Chinese Journal of Tissue Engineering Research. As a key member of the Chinese Society of Ethnomedicine and Pharmacy, he has been acknowledged for his research on the pharmacological mechanisms of traditional Mongolian medicine. His contributions to microbiology and immunology have been recognized by the Inner Mongolia Microbiology Society, and he has been invited as a young committee member of the Chinese Microbiological Society’s Clinical Microbiology Professional Committee.

🔬Research Focus:

Dr. Pengwei Zhao’s research primarily focuses on tumor immunology, cancer pharmacology, and the therapeutic potential of Mongolian medicine. He investigates the molecular mechanisms of β-defensins in cancer, particularly their role in immune regulation and tumor suppression. His work explores how β-defensin-1 peptides modulate PD-1/PD-L1 immune resistance in colorectal cancer. Additionally, he studies Mongolian medicinal formulations like Sendeng-4 and their mechanisms against skin cancer. His research also extends to microbiology, analyzing how bacterial infections, such as those caused by Staphylococcus aureus and Klebsiella pneumoniae, influence lung epithelial immune responses. Dr. Zhao has also contributed significantly to understanding long noncoding RNAs (lncRNAs) and their regulatory impact on autophagy pathways in cancer. His interdisciplinary approach integrates immunology, molecular biology, and ethnopharmacology, providing novel insights into cancer therapy, host-pathogen interactions, and the development of targeted immunotherapies.

Publication Top Notes:

Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis

Authors: P. Zhao, Pengwei; J. Cui, Jiaxian; X. Wang, Xiumei

Journal: Pharmacogenomics Journal

Year: 2024

Citations: 2

Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506

Authors: Y. Zhao, Yuxin; Y. Cui, Yan; X. Li, Xinhong; L. Bao, Lili; P. Zhao, Pengwei

Journal: World Journal of Gastrointestinal Oncology

Year: 2024

Citations: 3

Effect of Staphylococcus aureus in pneumonia mouse model on promotion of mBD-3 expression through ERK1/2

Authors: Yongqing Ni, Xiaoduo Bi, Pengwei Zhao

Ligilactobacillus salivarius LZZAY01 accelerated autophagy and apoptosis in colon cancer cells and improved gut microbiota in CAC mice

Authors: Yang W, Li T, An S, Chen R, Zhao Y, Cui J, Zhang M, Lu J, Tian Y, Bao L, Zhao P

Journal: Microbiol Spectrum

Year: 2025

LPS Promoted HPMEC Autophagy by Suppression of the PI3K/Akt/mTOR through Inhibited TIMAP-Promoted Moesin Expression in Sepsis

Authors: Jili Wen, Pengwei Zhao, HuiJuan Ren, JunMin Wu

Journal: Journal of Biological Regulators and Homeostatic Agents

Year: 2023

 

Dr. samira abozeid | Inorganic Chemistry Award | Best Researcher Award

Published on by Chemistry Awards

Dr. samira abozeid | Inorganic Chemistry Award | Best Researcher Award

Dr. samira abozeid,mansoura university,Egypt

Dr. Samira Abozeid is a dedicated Lecturer and Assistant Professor in the Chemistry Department at Mansoura University, Egypt. With a strong academic background, she earned her Ph.D. in Chemistry from the State University of New York at Buffalo, complemented by an MSc and BSc from Mansoura University. Dr. Abozeid specializes in synthesizing metal complexes for applications in MRI contrast agents and drug delivery systems using innovative nanotechnology. Her commitment to academic excellence is evident through her extensive research contributions, collaborative efforts, and participation in various national and international projects. Additionally, she has been recognized with several awards for her outstanding research and teaching, showcasing her dedication to advancing the field of chemistry and contributing to educational initiatives.

Professional Profile:

Google Scholar

Scopus

Orcid

Summary of Suitability for Award:

Dr. Samira Mohammed Abozeid exemplifies the qualities and achievements that make her a suitable candidate for the “Best Researcher Award.” With a Ph.D. in Chemistry from the State University of New York at Buffalo, she has made significant contributions to the field, particularly in synthesizing metal complexes for MRI contrast agents and drug delivery systems. Her publication record, which includes 18 articles in high-impact journals, underscores her prolific research output and the relevance of her work in advancing medical applications of chemistry.

🎓Education:

Dr. Samira Abozeid holds an impressive academic portfolio. She completed her Bachelor’s and Master’s degrees in Chemistry at Mansoura University, Egypt, where she developed a solid foundation in chemical sciences. Dr. Abozeid then pursued her Ph.D. at the State University of New York at Buffalo, specializing in the synthesis of metal complexes and their applications in medical imaging and drug delivery. Her doctoral research significantly contributed to the understanding of MRI contrast agents, showcasing her capability to conduct high-level research. Throughout her academic journey, she has maintained a focus on integrating theoretical knowledge with practical applications, which has enriched her teaching methodologies and research approach. Dr. Abozeid’s education has equipped her with the skills to excel in both academia and research, fostering a commitment to innovation in chemistry.

🏢Work Experience:

Dr. Samira Abozeid has garnered extensive experience in academia and research throughout her career. Currently serving as a Lecturer and Assistant Professor at both Mansoura University and New Mansoura University, she plays a pivotal role in educating and mentoring students in chemistry. Dr. Abozeid has completed three significant research projects focused on the synthesis and characterization of metal complexes for MRI applications and drug delivery systems. With 18 published articles in esteemed journals and a citation index reflecting her impactful research contributions, she has established herself as a leading figure in her field. Furthermore, she has engaged in consultancy projects related to chemistry and has participated in multiple collaborative research efforts, both nationally and internationally, which have enriched her research perspective and facilitated knowledge exchange. Dr. Abozeid’s commitment to research excellence is complemented by her active involvement in professional memberships and initiatives aimed at bridging academic research with industry applications.

🏅Awards:

Dr. Samira Abozeid has received several prestigious awards and recognitions throughout her academic career. Among her notable accolades is the Egyptian Government Scholarship, which allowed her to pursue her studies at the State University of New York at Buffalo from 2016 to 2018. Additionally, she was honored with the James T. Grey, Jr. Fellowship in Summer 2020, which acknowledges outstanding research contributions. Dr. Abozeid also received the Mattern-Tyler Teaching Award and the Speyer Fellowship in Fall 2020, reflecting her excellence in both teaching and research. In 2023, she was awarded a competitively funded research project at Mansoura University, highlighting her commitment to advancing scientific knowledge. Furthermore, she has been recognized for delivering the Best Specialized Lecture at multiple conferences, showcasing her ability to communicate complex scientific ideas effectively. These honors underline her significant contributions to the field of chemistry and her dedication to academic excellence.

🔬Research Focus:

Dr. Samira Abozeid’s research focuses primarily on the synthesis and application of metal complexes, particularly in the development of MRI contrast agents and drug delivery systems. Her innovative approach involves utilizing nanoparticles and liposomes to enhance the effectiveness and biocompatibility of these complexes. Dr. Abozeid’s work emphasizes the importance of transition metal complexes in medical applications, providing novel insights into their structural properties and potential therapeutic uses. Her ongoing projects include the development of more effective and safer MRI probes, which can significantly improve diagnostic imaging capabilities. Additionally, she collaborates with national and international research groups to explore energy-related applications of metal complexes. Through her research, Dr. Abozeid aims to bridge the gap between chemistry and medicine, contributing to advancements in nanotechnology and its practical implications for healthcare. Her commitment to innovation and excellence continues to shape her contributions to the scientific community.

Publication Top Notes:

  • Two New Inner-Sphere Pt(II) Thiosemicarbazone Schiff Base Complexes Immobilized into Magnetic Nanoparticles: Synthesis, Characterization, and Biological Investigations
  • A Novel Fluorescent Probe Based Imprinted Polymer-Coated Magnetite for the Detection of Imatinib Leukemia Anti-Cancer Drug Traces in Human Plasma Samples
  • Fe(III) T1 MRI Probes Containing Phenolate or Hydroxypyridine-Appended Triamine Chelates and a Coordination Site for Bound Water
    • Citations: 5 citations.
  • Co(II) Complexes of Tetraazamacrocycles Appended with Amide or Hydroxypropyl Groups as ParaCEST Agents
    • Citations: 3 citations.
  • Comparison of Phosphonate, Hydroxypropyl and Carboxylate Pendants in Fe(III) Macrocyclic Complexes as MRI Contrast Agents
    • Citations: 18 citations.